What Your IP Is Worth to Someone Who Isn't You

A CT scanner silhouette from the machine that made the point and lost the market.

I've sat through many IP valuation exercises and the pattern repeats every time. A management team pulls together its patents, trademarks, and proprietary processes, and asks one question: what do we have? The better question is different. What does this let someone else do?

That single shift changes how you think about patents, software, proprietary data, trade secrets, and brand equity. It's the question a buyer asks, a competitor asks, and a foreign entrant sizing up your market asks before making a single call to your team. Most companies never ask it about themselves.

The View From Inside Is Always Too Small

Internal valuation almost always starts with cost. What did the research cost, the filings cost, what does the portfolio cost to maintain each year? Those numbers matter for accounting. They tell you almost nothing about what the portfolio is worth in a transaction.

Cost-based thinking treats intellectual property the way a homeowner treats a kitchen renovation. You know what you spent. The market doesn't care. Familiarity compounds the problem. Leadership teams that have lived with a technology for a decade know its struggles and its limitations, and that closeness breeds a quiet dismissiveness. They see the flaws. An outside buyer sees only the solution to a pressing need.

Ocean Tomo, the intellectual property advisory firm, has tracked this shift for five decades through its Intangible Asset Market Value Study. In 1975, tangible assets made up 83 percent of S&P 500 market capitalization. By the end of 2025, that relationship had inverted almost completely, with intangibles accounting for roughly 92 percent of the index's value.

Baruch Lev, an accounting and finance professor at New York University, built much of his foundational research on a related point in his book Intangibles: Management, Measurement, and Reporting. Unlike a piece of equipment that generates value the moment it's installed, an intangible asset rarely creates cash flow on its own. Its worth is bound up with the complementary assets required to put it to work. A patented drug molecule is worthless without a manufacturing plant and a sales force behind it. The asset and its context are inseparable, which is exactly why two owners of the identical patent can arrive at two entirely different valuations.

What Your IP Is Worth Depends on Who's Asking

Ask three executives inside the same company what their IP is worth and you'll usually get three versions of the same conservative number, because internal teams anchor on what they already know. Ask a buyer, and the number moves, sometimes by an order of magnitude, because what your IP is worth to a buyer has nothing to do with your roadmap and everything to do with theirs.

Three types of buyers tend to move that number the most. A foreign market entrant sees your domestic patent portfolio as a readymade shield against local litigation. A company with a specific capability gap sees the fastest, cheapest alternative to years of research it doesn't have time to run. A rival planning a major expansion may see the portfolio purely as an obstruction to clear, with no intention of ever using the technology. Three buyers, three motivations, three prices, and the asset itself never changes.

Marcel Proust captured the underlying idea in the fifth volume of Remembrance of Things Past, writing about the limits of travel as a way to encounter anything genuinely new: "The only true voyage of discovery... would be not to visit strange lands but to possess other eyes, to behold the universe through the eyes of another, of a hundred others."

The insight translates directly to the boardroom. Your patent portfolio hasn't changed. The eyes looking at it have.

One of the clearest public examples of this pattern played out in the wireless patent market a little over a decade ago. When Nortel went bankrupt, its LTE patent portfolio drew a bidding war that ended with a $4.5 billion sale to the Rockstar Consortium, a group formed by Apple, Microsoft, and several other technology companies specifically to acquire it. Google had been part of the losing bid. Months later, Google closed a separate acquisition of a comparable LTE portfolio through its purchase of Motorola Mobility, paying roughly $5.5 billion for the patents inside a $12.5 billion deal. Two buyers, two portfolios, similar technology, and prices that had far more to do with each acquirer's own gap than with what either portfolio cost to create.

Neither Nortel nor Motorola built those patents with that price tag in mind. The market set it, and the market was made up entirely of people who weren't the original owner.

The Strategic Premium of Speed

Time is the one resource no company can manufacture more of, and strategic buyers pay for it every day. David Teece, an economist at the University of California, Berkeley, laid out the underlying mechanics in his 1986 paper Profiting from Technological Innovation: Implications for Integration, Collaboration, Licensing and Public Policy. His central finding was that innovators don't always capture the value of their own inventions. The winners are often whichever party controls the manufacturing scale and distribution networks needed to commercialize the breakthrough.

The CT scanner makes the point better than any statistic. EMI developed the technology in the 1970s, work that earned its engineer, Godfrey Hounsfield, a share of the 1979 Nobel Prize in Physiology or Medicine. Within a few years, GE and Siemens, with the hospital sales channels and manufacturing scale EMI never had, had overtaken the market, and EMI exited the business entirely. The breakthrough belonged to EMI. The value belonged to whoever could get it into hospitals faster, which is the same logic behind every acquisition premium paid for existing IP instead of a comparable internal build.

Redefining the Exercise

Instead of asking what a portfolio cost or what it currently generates in licensing revenue, a more useful exercise runs through a short list of outside perspectives:

• Who is currently blocked from a market this IP would open, and how much would that market be worth to them?

• Which competitors have spent years and capital trying to build around this exact capability?

• What would a strategic acquirer's roadmap look like if this portfolio disappeared from the negotiating table entirely?

None of these questions require a data room. They require a willingness to sit on the other side of the table before someone else forces you to.

The geography question deserves particular attention, and it's the one companies skip most often. A capability that looks mature in a home market can look like a shortcut somewhere else entirely. Regulatory requirements in Europe, manufacturing capacity across Asia, or an established distribution network in Latin America can each turn a US patent into an entry ticket for a company trying to leapfrog into a market it doesn't yet operate in. What your IP is worth inside your own borders and what it's worth to that company are rarely the same figure, and the gap is where a great deal of value sits unclaimed.

I'd add one more layer companies frequently skip. Defensive value rarely shows up in a spreadsheet, yet it can be the largest number in the room. A patent that keeps three competitors out of your core market is doing real financial work every quarter it exists, even though it never generates a licensing dollar. Ignore that value and you'll walk into a negotiation having already given away your strongest card.

Looking Beyond the Patent Portfolio

Patents are the easiest form of intellectual property to count, which is exactly why they aren't the whole picture. Proprietary manufacturing methods developed over years, internal software and data infrastructure, customer analytics built from a decade of relationships, training programs and operating frameworks, brand architecture, and confidential processes protected through trade secret practices all deserve the same scrutiny.

Viewed individually, each of those assets can look ordinary. Viewed together, they represent years of accumulated capability a competitor cannot quickly copy, and that cumulative effect is often where the largest premium hides. A company auditing only its patent filings is auditing a fraction of what it owns.

The Strategic Option You're Not Pricing

Outside-in valuation doesn't just change the number. It changes the options available to you. A company that understands its IP through a buyer's eyes can license selectively instead of defensively, and can walk into an M&A process, on either side of the table, with a clear sense of what the other party is actually buying rather than what the seller assumes it's selling. Left unexamined, the same blind spot has a cost outside a transaction too: unexplored licensing royalties, joint ventures that never form because a partner never learns what capabilities exist inside the walls, and capital budgets that keep favoring physical assets while intangibles grow unmanaged in the background.

That distinction shows up constantly in deal negotiations. Sellers who understand their IP only in cost terms leave value on the table because they never learn to argue from the buyer's need. Sellers who understand what their portfolio unlocks for a specific acquirer negotiate from a position that has nothing to do with what the balance sheet says. Boards should ask the outside-in question even with no deal on the horizon, because competitors and acquirers are reassessing that same portfolio on their own timeline regardless.

Your IP was never just an asset you built. The market rarely rewards a company for what it possesses alone. It rewards a company for what those assets make possible for someone else, whether you've done the math yet or not.

Where This Intersects With ACG

Executives rarely encounter this kind of gap in isolation. It shows up as a strategy question that becomes a finance question, then an operations question, then a leadership question about who owns the decision at all, often arriving mid-growth, mid-transition, or mid-acquisition interest, faster than existing bandwidth can absorb. Aspirations Consulting Group works with mid-market and Fortune 1000 executives at exactly these inflection points, bringing an outside perspective when internal capacity is stretched thin. If your organization is sitting on IP you've never valued through someone else's eyes, that's worth a confidential conversation. Reach us at https://www.aspirations-group.com.

Stay Ahead of the Next Decision

Insight like this is one piece of what ACG Strategic Insights publishes each weekday to more than 10 million current and aspiring executives worldwide. Request a complimentary subscription at https://www.aspirations-group.com/subscription and keep the thinking in front of you before the decision arrives.

Thanks for reading!

~ Jerry Justice

Living to Serve, Serving to Lead™